TL

The Lancet HIV

The Lancet HIV is a medical journal covering HIV research, policy, and clinical care.

Looking to publish in The Lancet HIV? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Immunology, Infectious Diseases
Impact Factor 13
Quartile Q1
Open Access Type Hybrid
ISSN 2352-3018
eISSN 2352-3018
Invitation Only No
Cost Range Manuscript submission is free; open access publication is available with an article processing charge (APC).

Submission Instructions

The Lancet HIV accepts the following article types. Click on an article type to view submission instructions.

Original Article

Cover Letter Cover letter is required and must be uploaded during online submission. Detailed responses to reviewers’ comments must be provided in a cover letter with revised submissions.
Abstract Abstract (semistructured Summary) is required and must not exceed 300 words. Summary must have five paragraphs: Background, Methods, Findings, Interpretation, and Funding.
Manuscript Main text limit is 3500 words (4500 for randomised controlled trial articles). A Research in context panel is required, and a data sharing statement must appear at the end of the manuscript.
References Maximum 30 references. Vancouver style: cite sequentially as superscript numbers after punctuation; list all authors if ≤6, or first 3 then et al if ≥7.
Figures & Tables Maximum 5 figures/tables/panels. Tables must be supplied as editable Word files (separate from main text), and figures must be supplied as editable files; clinical images must not use blackout bars for anonymisation.
Reformat to The Lancet HIV using Livewrite Premium

Review Article

Cover Letter Cover letter is required and must be uploaded at the “Enter Comments” stage of online submission. Revised submissions must include responses to reviewers’ comments in the cover letter.
Abstract A 150-word unstructured summary is required.
Manuscript Review Articles must be no more than 4500 words. Must include a “Search strategy and selection criteria” section.
References Maximum 75 references. Vancouver style: cite sequentially as superscript numbers; list all authors if ≤6, or first 3 then “et al” if ≥7.
Figures & Tables Up to six illustrations or tables are allowed. Figures and tables must be uploaded with the submission.
Reformat to The Lancet HIV using Livewrite Premium

Editorial

Cover Letter Covering letter is required and must be uploaded during online submission (Enter Comments stage).
Abstract Abstract requirement is not specified. Abstract word limit and structure are not specified.
Manuscript No manuscript word/page limit is specified. Title page must include brief title, author details/affiliations/addresses, and corresponding author contact information.
References No maximum reference count is indicated. References must use Vancouver superscript numbering in citation order; list all authors if ≤6, or first 3 then et al if ≥7.
Figures & Tables Figures are required; no maximum figure/table count is indicated. Tables must be supplied as a separate editable Word document; figures must be ≥300 dpi and at least 107 mm wide.
Reformat to The Lancet HIV using Livewrite Premium

Letter to the Editor

Cover Letter Cover letter is required and must be uploaded at the “Enter Comments” stage of online submission. Revised submissions must include detailed responses to reviewers’ comments in the cover letter.
Abstract Abstract requirement is not specified. Abstract word limit and structure are not specified.
Manuscript Letters for print publication must be ≤250 words and received within 4 weeks of the original item’s online publication; general-interest letters may be up to 400 words. Maximum of five authors is permitted.
References Maximum of five references. References must use Vancouver numbering, cited sequentially as superscript numbers after punctuation; list all authors if ≤6, or first three plus et al if ≥7.
Figures & Tables Maximum of one table or one figure. If figures are annotated, provide two separate files (annotated and non-annotated editable), and supply multi-part figures as individual parts plus a combined version.
Reformat to The Lancet HIV using Livewrite Premium

Systematic Review and Meta-analysis

Cover Letter Covering letter is required and must be uploaded at the “Enter Comments” stage of online submission. Revised submissions must include detailed responses to reviewers’ comments in the covering letter.
Abstract Structured Summary is required, maximum 300 words. Summary must contain no references.
Manuscript Main text must be 3500 words (systematic reviews/meta-analyses). Manuscript must be structured as Summary, Introduction, Methods, Results, and Discussion.
References References must aim for 75, comprising included studies plus up to 30 others. Vancouver style: cite sequentially as superscript numbers; list all authors if ≤6, or first three then “et al” if ≥7.
Figures & Tables Study-selection flow chart and a table of study characteristics are required. Figures must be supplied in editable formats (eg, Word/PowerPoint or .eps/.pdf).
Reformat to The Lancet HIV using Livewrite Premium

Recent Publications

Metabolic dysfunction-associated steatotic liver disease in people living with HIV: a framework for integrated screening and care

Giada Sebastiani, Tzu-Hao Lee, Ahmed Cordie, Felice Cinque, Jordan E Lake, Jeffrey V Lazarus, Jürgen K Rockstroh, Giovanni Guaraldi

10.1016/s2352-3018(26)00172-4
View Publication

Advancing a fixed-dose combination for children with HIV

Sharon Nachman

10.1016/s2352-3018(26)00199-2
View Publication

Targeted point-of-care HIV testing at birth for newborns at high risk of vertical transmission in Botswana: a prospective cohort study

Gbolahan Ajibola, Sean Brummel, Terence Mohammed, Maureen Sakoi-Mosetlhi, Kesaobaka Molebatsi, Oganne Batlang, Molly Pretorius Holme, Tendani Gaolathe, Modiegi Diseko, Max Kapanda, Jessica Mafa-Setswalo, Kathleen M Powis, Gwynn Stevens, Shahin Lockman, Joseph Makhema, Mathias Lichterfeld, Sikhulile Moyo, Roger Shapiro

10.1016/s2352-3018(26)00176-1
View Publication

Social sciences at the centre of HIV stigma reduction

Cristian Ortega, Alemka Tomicic

10.1016/s2352-3018(26)00223-7
View Publication

Low-level viraemia in children living with HIV

Bianca Alvarez, Patricia Agaba, Rosemary Mrina, Meagan Stephenson, Shirley Lecher

10.1016/s2352-3018(26)00224-9
View Publication

Frequently asked questions

How long does it take to publish?

Fast-track original research Articles are peer-reviewed within 3–5 days and, if accepted, published within 10 weeks from submission.

Reformat to The Lancet HIV using Livewrite Premium

Is a cover letter required?

A covering letter should be uploaded during online submission at the “Enter Comments” stage.

Reformat to The Lancet HIV using Livewrite Premium

What are the publication costs?

Manuscript submission is free; open access publication is available with an article processing charge (APC).

Reformat to The Lancet HIV using Livewrite Premium

Research Topics

HIV/AIDS Research and Interventions HIV, Drug Use, Sexual Risk HIV Research and Treatment HIV/AIDS drug development and treatment HIV-related health complications and treatments Adolescent Sexual and Reproductive Health Sex work and related issues HIV/AIDS Impact and Responses Pneumocystis jirovecii pneumonia detection and treatment Global Maternal and Child Health Global Public Health Policies and Epidemiology LGBTQ Health, Identity, and Policy Hepatitis C virus research Tuberculosis Research and Epidemiology Viral-associated cancers and disorders Poverty, Education, and Child Welfare Migration, Health and Trauma COVID-19 Clinical Research Studies Hepatitis B Virus Studies African Sexualities and LGBTQ+ Issues Vaccine Coverage and Hesitancy Syphilis Diagnosis and Treatment Pharmacological Effects and Toxicity Studies Cervical Cancer and HPV Research COVID-19 Impact on Reproduction

Related Journals

SI
Seminars in Immunology Elsevier BV
TJ
The Journal of Experimental Medicine Rockefeller University Press
AO
Annals of Allergy Asthma & Immunology Elsevier BV
IA
Influenza and Other Respiratory Viruses WILEY
JO
Journal of Global Antimicrobial Resistance Elsevier BV
CI
Cellular Immunology Elsevier BV